The magnitude of this reduction is particularly striking
Bypassingmajor Venous Occlusion and Duodenal Lesions in Rats, and Therapy with the Stable Gastricpentadecapeptide BPC 157, L-NAME and L-Arginine
BPC-157, however, remains intact in gastric juice and retains its biological activity after oral administration
doi:10.1093/ajcn/75.4.605
Want fat, muscle, and recovery data Need structured, measurable protocols Want measurable biological change, not guesswork Want enhanced performance and wellness optimization
HUBERMAN: One of the reasons why it's being used so extensively is that it does seem to have very high safety profiles, at least with respect